We are live on
!
Find out more
RDHL
Redhill Biopharma
RDHL
RDHL
1 hedge funds and large institutions have $281K invested in Redhill Biopharma in 2013 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Goldman Sachs
New York
| $278K | +$310K | +29 | New |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $3K | – | – | – |
|
RDHL Hedge Fund Activity: Q2 2013 in Review
1 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q2 2013, worth a combined $281K.
Buyers outnumbered sellers: 1 fund opened new RDHL positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
- 1 institutional investor held Redhill Biopharma (RDHL) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $281K of Redhill Biopharma stock for Q2 2013.
- 1 fund opened new Redhill Biopharma positions in Q2 2013 and 0 closed out, a net change of +1 holder.
Based on aggregated 13F filings for Q2 2013.